All News & Press

May 16, 2018

New Managing Director for CordenPharma Latina (IT)

May 16, 2018
Press Release > CordenPharma Appoints New Managing Director in CordenPharma Latina (IT)
May 3, 2018

Targeted Cancer Drugs Reshape Drug Manufacturing

May 03, 2018
Article > Parenteral Drug Manufacturing Panel Discussion
May 3, 2018

Oligonucleotide Development Trends

May 03, 2018
Article > Oligonucleotide Development Trends: Growing Interest In Oncology Therapies
May 1, 2018

Oligonucleotide API Manufacturing Expansion in US

May 01, 2018
Press Release > CordenPharma Announces Commercial Oligonucleotide API Manufacturing Expansion in CordenPharma Colorado
April 25, 2018

Pharma Congress 2018 – Continuous Manufacturing

Apr 25, 2018
Presentation > Continuous Manufacturing – A Case Study
April 17, 2018

Understanding Highly Potent Containment

Apr 17, 2018
Webinar > Critical Aspects of a Robust Highly Potent Compound Program: The Importance of Understanding Intangible Elements of Containment
April 4, 2018

Successful FDA Inspection for CordenPharma Boulder

Apr 04, 2018
News > CordenPharma Boulder Receives Successful FDA Inspection
April 4, 2018

Former Pfizer API Facility Offers Flexible Capabilities

Apr 04, 2018
Event > DCAT Week ’18: CordenPharma Outlines Integration of Former Pfizer API Facility
March 28, 2018

CordenPharma Receives CMO Leadership Awards

Mar 28, 2018
Event > CordenPharma Receives Life Science Leader CMO Leadership Awards during DCAT 2018
February 13, 2018

CordenPharma Revamps Executive Leadership Team

Feb 13, 2018
Press Release > CordenPharma Announces Revamped Executive Leadership Team
December 8, 2017

Growth Strategies for Pharma Chemical Makers

Dec 08, 2017
Article > Interview with Dr. Michael Quirmbach at CPhI 2017
November 20, 2017

Oligonucleotides: Promising Therapeutics, Challenges

Nov 20, 2017
Article > Oligonucleotides: Promising Therapeutics With Significant Challenges
November 20, 2017

Pharma Horizon With Dr. Matthieu Giraud

Nov 20, 2017
Article > 5 Minutes at CPhI 2017 with Dr. Matthieu Giraud
November 20, 2017

New Highly Potent Acquisition Enhances Capacity

Nov 20, 2017
Article > Brian McCudden Discusses New CordenPharma Boulder Acquisition
November 14, 2017

New Highly Potent Lab Increases Flexibility, Scale-up

Nov 14, 2017
Article > Success Factor - Containment: Glatt & CordenPharma